From left: Mr George Kazzi, General Manager, Baxter Malaysia; Y.Bhg. Dato’ Zamzuri bin Abdul Aziz, Deputy Secretary General (Finance), MOH; Ms Aida Basri, Government Affairs & Market Access Lead, Medtronic Malaysia; Mr CS Ching, Executive Director, AMMI; Y.Bhg. Dato’ Seri Dr Haji Haminnuddin bin Haji Abd. Hamid, Secretary General, AMMI; Mr Andy Lee, Chairman, AMMI; YB Khairy Jamaluddin, Minister of Health; Y.Bhg. Tan Sri Dato’ Seri Dr Noor Hisham bin Abdullah, Director General of Health; Dr Mohd Emil Azril Bahari Md Noor, General Manager, Government Affairs & Market Access, B. Braun; Mr Samuel Pooranakaran, Vice Chairman, AMMI.
Putrajaya, 5 October 2022 – AMMI Chairman Mr Andy Lee led Board members and Government Affairs Committee members to make a courtesy call on YB Khairy Jamaluddin, Minister of Health, today, 5 October 2022. The meeting was attended by the Top Management of the Ministry of Health (MOH), including Tan Sri Dato’ Seri Dr Noor Hisham bin Abdullah, Director General of Health, Dato’ Zamzuri bin Abdul Aziz, Deputy Secretary General (Finance), MOH and Mr Ahmad Shariff bin Hambali, Chief Executive, Medical Device Authority. YB Minister of Health, Top Management of MOH and Chief Executive of MDA responded positively to our proposal to improve the Medical Device Act (Act 737) to:-
- Include renewal/re-registration clause, which specifies auto-renewal for medical device registration (product registration);
- Confine the post-market surveillance & vigilance requirement to local cases only;
- Exclude the export of medical devices from the scope of the Medical Device Act.
At the end of the meeting, AMMI Chairman Mr Andy Lee presented a mock cheque of RM250,000 to YB Minister of Health to signify our contribution to MOH’s Covid-19 Fund (Sumbangan Perubatan KKM) on 9 March 2022 during the Omicron wave.
Note: The donation of RM250,000 to support the public healthcare system to fight against COVID-19 was approved by AMMI members in the Extraordinary General Meeting (EGM) held on 28 October 2021.